biopsychosocial limited Company Information
Company Number
05765922
Website
-Registered Address
first floor office, westerham garage, westerham, kent, TN16 2DJ
Industry
Other human health activities
Telephone
-
Next Accounts Due
December 2025
Group Structure
View All
Directors
Jenny Radcliffe17 Years
Shareholders
jenny radcliffe 100%
biopsychosocial limited Estimated Valuation
Pomanda estimates the enterprise value of BIOPSYCHOSOCIAL LIMITED at £64.4k based on a Turnover of £118.7k and 0.54x industry multiple (adjusted for size and gross margin).
biopsychosocial limited Estimated Valuation
Pomanda estimates the enterprise value of BIOPSYCHOSOCIAL LIMITED at £0 based on an EBITDA of £-56.8k and a 4.76x industry multiple (adjusted for size and gross margin).
biopsychosocial limited Estimated Valuation
Pomanda estimates the enterprise value of BIOPSYCHOSOCIAL LIMITED at £211.4k based on Net Assets of £89k and 2.38x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Biopsychosocial Limited Overview
Biopsychosocial Limited is a live company located in westerham, TN16 2DJ with a Companies House number of 05765922. It operates in the other human health activities sector, SIC Code 86900. Founded in April 2006, it's largest shareholder is jenny radcliffe with a 100% stake. Biopsychosocial Limited is a established, micro sized company, Pomanda has estimated its turnover at £118.7k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Biopsychosocial Limited Health Check
Pomanda's financial health check has awarded Biopsychosocial Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
2 Regular
5 Weak
Size
annual sales of £118.7k, make it smaller than the average company (£630.6k)
- Biopsychosocial Limited
£630.6k - Industry AVG
Growth
3 year (CAGR) sales growth of -25%, show it is growing at a slower rate (7.2%)
- Biopsychosocial Limited
7.2% - Industry AVG
Production
with a gross margin of 37.5%, this company has a comparable cost of product (37.5%)
- Biopsychosocial Limited
37.5% - Industry AVG
Profitability
an operating margin of -48.2% make it less profitable than the average company (5%)
- Biopsychosocial Limited
5% - Industry AVG
Employees
with 1 employees, this is below the industry average (16)
1 - Biopsychosocial Limited
16 - Industry AVG
Pay Structure
on an average salary of £25.5k, the company has an equivalent pay structure (£25.5k)
- Biopsychosocial Limited
£25.5k - Industry AVG
Efficiency
resulting in sales per employee of £118.7k, this is more efficient (£45.3k)
- Biopsychosocial Limited
£45.3k - Industry AVG
Debtor Days
it gets paid by customers after 44 days, this is later than average (21 days)
- Biopsychosocial Limited
21 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Biopsychosocial Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Biopsychosocial Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 222 weeks, this is more cash available to meet short term requirements (130 weeks)
222 weeks - Biopsychosocial Limited
130 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 12.7%, this is a lower level of debt than the average (21.9%)
12.7% - Biopsychosocial Limited
21.9% - Industry AVG
BIOPSYCHOSOCIAL LIMITED financials
Biopsychosocial Limited's latest turnover from March 2024 is estimated at £118.7 thousand and the company has net assets of £89 thousand. According to their latest financial statements, Biopsychosocial Limited has 1 employee and maintains cash reserves of £55.6 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Apr 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | |||||||||||||||
Tax | |||||||||||||||
Profit After Tax | |||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | |||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 1 | 1 | 1 | 1 | 1 | ||||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Apr 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 31,969 | 31,792 | 31,579 | 31,279 | 31,406 | 31,577 | 31,803 | 31,607 | 30,944 | 30,960 | 30,985 | 31,015 | 159 | 212 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 31,969 | 31,792 | 31,579 | 31,279 | 31,406 | 31,577 | 31,803 | 31,607 | 30,944 | 30,960 | 30,985 | 31,015 | 159 | 212 | 0 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 14,320 | 0 | 7,650 | 40,050 | 28,350 | 9,900 | 11,750 | 3,870 | 334 | 2,504 | 8,790 | 2,750 | 0 | 15,534 | 27,500 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 51,000 | 51,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 55,557 | 64,817 | 59,763 | 58,175 | 50,439 | 49,655 | 31,564 | 24,277 | 10,067 | 3,469 | 31,590 | 27,792 | 24,037 | 1,784 | 0 |
misc current assets | 84 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 69,961 | 115,817 | 118,413 | 98,225 | 78,789 | 59,555 | 43,314 | 28,147 | 10,401 | 5,973 | 40,380 | 30,542 | 24,037 | 17,318 | 27,500 |
total assets | 101,930 | 147,609 | 149,992 | 129,504 | 110,195 | 91,132 | 75,117 | 59,754 | 41,345 | 36,933 | 71,365 | 61,557 | 24,196 | 17,530 | 27,500 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 0 | 0 | 0 | 12,056 | 10,371 | 0 | 24 | 36 | 14,821 | 36,709 | 40,017 | 43,756 | 11,692 | 7,548 | 6,731 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 12,968 | 4,461 | 17,383 | 0 | 0 | 10,555 | 9,839 | 12,404 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 12,968 | 4,461 | 17,383 | 12,056 | 10,371 | 10,555 | 9,863 | 12,440 | 14,821 | 36,709 | 40,017 | 43,756 | 11,692 | 7,548 | 6,731 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 12,968 | 4,461 | 17,383 | 12,056 | 10,371 | 10,555 | 9,863 | 12,440 | 14,821 | 36,709 | 40,017 | 43,756 | 11,692 | 7,548 | 6,731 |
net assets | 88,962 | 143,148 | 132,609 | 117,448 | 99,824 | 80,577 | 65,254 | 47,314 | 26,524 | 224 | 31,348 | 17,801 | 12,504 | 9,982 | 20,769 |
total shareholders funds | 88,962 | 143,148 | 132,609 | 117,448 | 99,824 | 80,577 | 65,254 | 47,314 | 26,524 | 224 | 31,348 | 17,801 | 12,504 | 9,982 | 20,769 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Apr 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 357 | 299 | 228 | 127 | 171 | 226 | 303 | 16 | 25 | 30 | 40 | 53 | 70 | 0 | |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6,000 | |
Tax | |||||||||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | -36,680 | -7,650 | 18,600 | 11,700 | 18,450 | -1,850 | 7,880 | 3,536 | -2,170 | -6,286 | 6,040 | 2,750 | -15,534 | -11,966 | 27,500 |
Creditors | 0 | 0 | -12,056 | 1,685 | 10,371 | -24 | -12 | -14,785 | -21,888 | -3,308 | -3,739 | 32,064 | 4,144 | 817 | 6,731 |
Accruals and Deferred Income | 8,507 | -12,922 | 17,383 | 0 | -10,555 | 716 | -2,565 | 12,404 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | |||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | -9,260 | 5,054 | 1,588 | 7,736 | 784 | 18,091 | 7,287 | 14,210 | 6,598 | -28,121 | 3,798 | 3,755 | 22,253 | 1,784 | 0 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -9,260 | 5,054 | 1,588 | 7,736 | 784 | 18,091 | 7,287 | 14,210 | 6,598 | -28,121 | 3,798 | 3,755 | 22,253 | 1,784 | 0 |
biopsychosocial limited Credit Report and Business Information
Biopsychosocial Limited Competitor Analysis
Perform a competitor analysis for biopsychosocial limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in TN16 area or any other competitors across 12 key performance metrics.
biopsychosocial limited Ownership
BIOPSYCHOSOCIAL LIMITED group structure
Biopsychosocial Limited has no subsidiary companies.
Ultimate parent company
BIOPSYCHOSOCIAL LIMITED
05765922
biopsychosocial limited directors
Biopsychosocial Limited currently has 1 director, Ms Jenny Radcliffe serving since Dec 2006.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Ms Jenny Radcliffe | England | 60 years | Dec 2006 | - | Director |
P&L
March 2024turnover
118.7k
0%
operating profit
-57.2k
0%
gross margin
37.5%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
89k
-0.38%
total assets
101.9k
-0.31%
cash
55.6k
-0.14%
net assets
Total assets minus all liabilities
biopsychosocial limited company details
company number
05765922
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
April 2006
age
18
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
audioerotica limited (March 2010)
gh28 limited (December 2006)
accountant
AFS ACCOUNTANTS
auditor
-
address
first floor office, westerham garage, westerham, kent, TN16 2DJ
Bank
-
Legal Advisor
-
biopsychosocial limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to biopsychosocial limited.
biopsychosocial limited Companies House Filings - See Documents
date | description | view/download |
---|